GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Inoviq Ltd (ASX:IIQ) » Definitions » 10-Year ROIIC %

Inoviq (ASX:IIQ) 10-Year ROIIC % : -104.71% (As of Jun. 2024)


View and export this data going back to 1991. Start your Free Trial

What is Inoviq 10-Year ROIIC %?

10-Year Return on Invested Incremental Capital (10-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 10-year. Inoviq's 10-Year ROIIC % for the quarter that ended in Jun. 2024 was -104.71%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Inoviq's 10-Year ROIIC % or its related term are showing as below:

ASX:IIQ's 10-Year ROIIC % is ranked worse than
86.14% of 202 companies
in the Medical Diagnostics & Research industry
Industry Median: -0.07 vs ASX:IIQ: -104.71

Inoviq 10-Year ROIIC % Historical Data

The historical data trend for Inoviq's 10-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inoviq 10-Year ROIIC % Chart

Inoviq Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
10-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.24 -147.34 366.79 -127.01 -104.71

Inoviq Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
10-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 366.79 - -127.01 - -104.71

Competitive Comparison of Inoviq's 10-Year ROIIC %

For the Diagnostics & Research subindustry, Inoviq's 10-Year ROIIC %, along with its competitors' market caps and 10-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inoviq's 10-Year ROIIC % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Inoviq's 10-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Inoviq's 10-Year ROIIC % falls into.



Inoviq 10-Year ROIIC % Calculation

Inoviq's 10-Year ROIIC % for the quarter that ended in Jun. 2024 is calculated as:

10-Year ROIIC %=10-Year Incremental Net Operating Profit After Taxes (NOPAT)**/10-Year Incremental Invested Capital**
=( -7.837 (Jun. 2024) - -0.573 (Jun. 2014) )/( 11.552 (Jun. 2024) - 4.615 (Jun. 2014) )
=-7.264/6.937
=-104.71%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 10-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Inoviq  (ASX:IIQ) 10-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Inoviq 10-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Inoviq's 10-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Inoviq Business Description

Traded in Other Exchanges
N/A
Address
23 Normanby Road, Notting Hill, Melbourne, VIC, AUS, 3168
Inoviq Ltd is engaged in developing and commercializing a portfolio of diagnostic and exosome-based products to improve the diagnosis and treatment of cancer and other diseases. The company has commercialized the hTERT test used as an adjunct to urine cytology testing for bladder cancer and the EXO-NET pan-exosome capture tool for research purposes. Its cancer diagnostic pipeline includes blood tests in development for earlier detection and monitoring of ovarian, breast, prostate, and other cancers.

Inoviq Headlines

No Headlines